Top 10 Pharma company doubles high-performing site count in a priority indication

A top 10 biopharmaceutical company wanted to expand their site list in a priority indication and gain a deeper understanding of how existing sites in their database performed. Medidata Acorn AI integrated cross-industry clinical trial data with the sponsor’s data to create a more robust view of site performance. Read the case study to learn how Acorn AI more than doubled the number of Tier 1, high performing sites for the sponsor to select from.

Request Free!